# EXL01 listing is produced correctly

    Code
      result
    Output
      Listing of Exposure to Study Drug
      
      ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————
                                          Study Day   Study Day                                                          
      Center/Subject ID       Visit         From         To         Treatment      Dose   Unit   Frequency      Route    
      ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      BRA-1/id-105        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      BRA-1/id-134        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      BRA-1/id-141        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      BRA-1/id-236        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      BRA-1/id-265        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      BRA-1/id-42         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      BRA-1/id-65         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      BRA-1/id-93         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      BRA-11/id-171       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      BRA-11/id-217       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      BRA-11/id-237       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      BRA-11/id-321       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1440    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      BRA-11/id-345       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      BRA-11/id-397       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      BRA-11/id-50        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      BRA-11/id-9         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      BRA-12/id-59        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      BRA-13/id-177       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      BRA-14/id-120       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      BRA-14/id-23        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      BRA-15/id-36        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      BRA-2/id-101        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
      BRA-2/id-296        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      BRA-3/id-13         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      BRA-3/id-8          SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      BRA-4/id-368        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      BRA-4/id-383        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      BRA-5/id-234        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      BRA-6/id-369        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      BRA-7/id-301        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CAN-1/id-18         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      CAN-1/id-341        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CAN-11/id-139       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CAN-11/id-306       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      CAN-14/id-104       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      CAN-4/id-324        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CAN-4/id-331        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CAN-5/id-121        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-107        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-119        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-12         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-123        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-133        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-144        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-156        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-1/id-16         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-163        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
      CHN-1/id-181        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-186        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-1/id-197        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-199        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-208        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-212        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-1/id-216        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-227        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-1/id-229        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-232        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-233        SCREENING          -1          -1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-235        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-25         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-253        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-26         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-275        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-276        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-277        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-279        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-287        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-288        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-1/id-307        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-312        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      SUBCUTANEOUS
      CHN-1/id-315        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-316        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      CHN-1/id-329        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      CHN-1/id-33         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-336        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-337        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-344        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-346        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-347        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      SUBCUTANEOUS
      CHN-1/id-351        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-1/id-360        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-371        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-376        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      CHN-1/id-389        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      CHN-1/id-400        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-47         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      SUBCUTANEOUS
      CHN-1/id-53         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-62         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-64         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-69         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-1/id-71         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-1/id-74         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-78         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-1/id-86         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-1/id-97         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-10/id-380       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
      CHN-11/id-113       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-116       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      1440    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      CHN-11/id-124       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      CHN-11/id-132       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
      CHN-11/id-146       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   480     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-153       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-158       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      SUBCUTANEOUS
      CHN-11/id-167       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-174       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-11/id-184       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      CHN-11/id-192       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-2         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-11/id-220       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-222       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      CHN-11/id-24        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-11/id-244       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      CHN-11/id-246       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-11/id-247       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-256       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
      CHN-11/id-257       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-263       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      CHN-11/id-27        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-11/id-278       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-289       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-291       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-298       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-11/id-317       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-318       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-349       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-354       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-356       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-358       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-11/id-362       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-364       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-377       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-11/id-379       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-38        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-386       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-391       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-11/id-392       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-54        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-11/id-55        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      CHN-11/id-60        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-11/id-63        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-11/id-75        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-88        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      480     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      CHN-11/id-90        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-11/id-91        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      SUBCUTANEOUS
      CHN-12/id-255       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-12/id-258       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      CHN-12/id-266       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-12/id-285       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-12/id-294       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-12/id-322       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-12/id-396       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      CHN-12/id-57        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      CHN-13/id-102       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
      CHN-13/id-166       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      CHN-13/id-19        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-13/id-239       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-13/id-240       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-13/id-249       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-13/id-270       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-13/id-304       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-14/id-1         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      480     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-14/id-103       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-14/id-143       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-14/id-161       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-14/id-168       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-14/id-228       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-14/id-305       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-14/id-375       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-14/id-56        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-15/id-14        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-15/id-201       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      CHN-15/id-245       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      CHN-15/id-262       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      CHN-15/id-297       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-15/id-399       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-16/id-154       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-16/id-241       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-16/id-302       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-16/id-323       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-16/id-352       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-16/id-381       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-17/id-10        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      CHN-17/id-129       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-17/id-182       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      CHN-17/id-209       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      CHN-17/id-309       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-17/id-31        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-17/id-48        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-17/id-5         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-17/id-66        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-17/id-84        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      CHN-17/id-92        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
      CHN-18/id-106       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-18/id-170       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-18/id-51        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-2/id-118        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-2/id-149        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-2/id-22         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      SUBCUTANEOUS
      CHN-2/id-223        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-2/id-272        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-2/id-274        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-2/id-284        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
      CHN-2/id-286        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      CHN-2/id-292        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-2/id-332        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-2/id-34         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-2/id-342        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      CHN-2/id-367        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-2/id-395        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-2/id-398        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
      CHN-2/id-98         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-3/id-128        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-3/id-155        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-3/id-193        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-3/id-204        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-3/id-259        SCREENING          -1          -1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-3/id-271        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      CHN-3/id-281        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      CHN-3/id-303        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-3/id-333        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
      CHN-3/id-361        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-3/id-81         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      CHN-4/id-114        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      CHN-4/id-115        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   480     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
      CHN-4/id-122        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-4/id-310        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-4/id-311        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-4/id-335        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-4/id-370        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-4/id-67         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      CHN-4/id-73         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-5/id-108        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      CHN-5/id-159        SCREENING          -1          -1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      SUBCUTANEOUS
      CHN-5/id-160        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-5/id-175        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-5/id-195        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-5/id-221        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      CHN-5/id-231        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-5/id-273        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
      CHN-5/id-338        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-5/id-348        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      CHN-5/id-83         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      CHN-6/id-248        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-6/id-30         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-6/id-385        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
      CHN-6/id-89         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-7/id-126        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-7/id-202        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      CHN-7/id-267        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-7/id-28         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      CHN-7/id-290        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      CHN-7/id-40         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-8/id-205        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      CHN-8/id-299        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      CHN-9/id-11         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      CHN-9/id-147        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      CHN-9/id-374        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
      GBR-1/id-319        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      GBR-1/id-355        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      GBR-1/id-384        SCREENING          -1          -1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      GBR-11/id-340       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      GBR-11/id-390       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      GBR-13/id-80        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      GBR-15/id-293       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      GBR-17/id-211       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      GBR-6/id-111        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      JPN-1/id-21         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      JPN-1/id-218        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      JPN-1/id-225        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      JPN-1/id-300        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      JPN-1/id-7          SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
      JPN-11/id-135       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      JPN-11/id-373       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      JPN-11/id-61        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      JPN-12/id-219       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      JPN-14/id-194       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      JPN-17/id-250       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      JPN-17/id-393       SCREENING          -1          -1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      JPN-18/id-189       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      JPN-2/id-214        SCREENING          -1          -1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      JPN-3/id-109        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      JPN-5/id-252        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   480     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      JPN-5/id-326        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      JPN-6/id-260        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      NGA-1/id-172        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      NGA-1/id-198        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      NGA-1/id-200        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      NGA-1/id-325        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      NGA-1/id-327        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      NGA-1/id-357        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      NGA-1/id-388        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
      NGA-1/id-43         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      SUBCUTANEOUS
      NGA-1/id-46         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      NGA-1/id-96         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      NGA-11/id-173       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      SUBCUTANEOUS
      NGA-11/id-313       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      NGA-11/id-334       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      NGA-11/id-35        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      NGA-11/id-366       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      NGA-11/id-41        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      NGA-12/id-264       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      NGA-12/id-387       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      NGA-17/id-230       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      NGA-17/id-72        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      NGA-2/id-308        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      NGA-2/id-353        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
      NGA-4/id-215        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      NGA-4/id-37         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      NGA-5/id-99         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      NGA-6/id-363        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      PAK-1/id-112        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
      PAK-1/id-125        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      PAK-1/id-148        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      PAK-1/id-169        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      PAK-1/id-17         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      PAK-1/id-178        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      PAK-1/id-280        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      PAK-1/id-39         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      PAK-1/id-79         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      480     mg      ONCE      INTRAVENOUS 
      PAK-1/id-95         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      PAK-11/id-145       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      PAK-11/id-187       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      PAK-11/id-210       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      PAK-11/id-268       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      PAK-11/id-330       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      PAK-11/id-49        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      PAK-11/id-68        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
      PAK-11/id-82        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      PAK-11/id-87        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      PAK-12/id-328       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      PAK-12/id-85        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      PAK-13/id-251       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      PAK-13/id-350       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      PAK-14/id-117       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      PAK-15/id-314       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      PAK-2/id-188        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      PAK-2/id-191        SCREENING          -1          -1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      PAK-2/id-213        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      PAK-4/id-15         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      PAK-4/id-164        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      PAK-5/id-20         SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      RUS-1/id-52         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      RUS-11/id-162       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      RUS-11/id-283       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
      RUS-11/id-76        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      RUS-11/id-94        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      RUS-12/id-185       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      RUS-13/id-70        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      RUS-14/id-183       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      RUS-16/id-165       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      RUS-16/id-4         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      RUS-18/id-359       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      RUS-2/id-176        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
      RUS-3/id-378        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      RUS-4/id-150        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      RUS-4/id-180        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      RUS-4/id-6          SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      RUS-5/id-29         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      RUS-6/id-77         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      RUS-7/id-243        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      USA-1/id-137        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      USA-1/id-138        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      USA-1/id-207        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      USA-1/id-242        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      INTRAVENOUS 
      USA-1/id-254        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      USA-1/id-261        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      USA-1/id-269        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     1200    mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      USA-1/id-295        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      USA-1/id-394        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     1200    mg      ONCE      INTRAVENOUS 
      USA-1/id-45         SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      USA-11/id-100       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      INTRAVENOUS 
      USA-11/id-136       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      USA-11/id-157       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      USA-11/id-203       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      USA-11/id-224       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
      USA-11/id-238       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      USA-11/id-32        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
      USA-11/id-339       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      USA-11/id-365       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      USA-12/id-131       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
      USA-12/id-140       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      USA-12/id-152       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      USA-12/id-226       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      USA-12/id-343       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      USA-12/id-44        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   960     mg      ONCE      SUBCUTANEOUS
      USA-14/id-196       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 1 DAY 8        8           8         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      960     mg      ONCE      INTRAVENOUS 
      USA-15/id-127       SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      USA-15/id-372       SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1200    mg      ONCE      INTRAVENOUS 
      USA-17/id-142       SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      1440    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      USA-17/id-3         SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     960     mg      ONCE      INTRAVENOUS 
      USA-19/id-58        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   480     mg      ONCE      SUBCUTANEOUS
      USA-2/id-110        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   1440    mg      ONCE      INTRAVENOUS 
      USA-3/id-282        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         A: Drug X      480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 
      USA-3/id-320        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      USA-4/id-190        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     480     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     720     mg      ONCE      INTRAVENOUS 
      USA-4/id-382        SCREENING          -1          -1       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1       C: Combination   1200    mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      SUBCUTANEOUS
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      SUBCUTANEOUS
      USA-5/id-179        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      USA-6/id-151        SCREENING          -1          -1         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          BASELINE            1           1         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         B: Placebo     720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         B: Placebo     960     mg      ONCE      SUBCUTANEOUS
                          WEEK 3 DAY 22      22          22         B: Placebo     720     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         B: Placebo     480     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         B: Placebo     480     mg      ONCE      INTRAVENOUS 
      USA-8/id-206        SCREENING          -1          -1       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1       C: Combination   720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 4 DAY 29      29          29       C: Combination   960     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36       C: Combination   720     mg      ONCE      INTRAVENOUS 
      USA-9/id-130        SCREENING          -1          -1         A: Drug X      960     mg      ONCE      INTRAVENOUS 
                          BASELINE            1           1         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 1 DAY 8        8           8         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 2 DAY 15      15          15         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 3 DAY 22      22          22         A: Drug X      960     mg      ONCE      SUBCUTANEOUS
                          WEEK 4 DAY 29      29          29         A: Drug X      720     mg      ONCE      INTRAVENOUS 
                          WEEK 5 DAY 36      36          36         A: Drug X      720     mg      ONCE      INTRAVENOUS 

